{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T09:40:54Z","timestamp":1778233254388,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007642","name":"Universit\u00e0 degli Studi di Roma Tor Vergata","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007642","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007642","name":"Universit\u00e0 degli Studi di Roma Tor Vergata","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007642","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Updates Surg"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Identifying preoperatively cases of more indolent papillary thyroid carcinoma  (PTC)could be of high interest. The aim of this study was to verify previously published data on the prognostic value of fine needle aspiration cytology  (FNAC)in PTC, also comparing findings from high-volume (HV)and low-volume (LV)institutions. From January 2022 to June 2024, the institutional database of the endocrinological surgery unit of Sant\u2019Eugenio Hospital (Rome, Italy)was retrospectively reviewed to select patients who underwent thyroid surgery for PTC. To evaluate the prognostic value of presurgical FNAC, all histological features and the ATA risk of the study groups were compared. Later, data of patients entirely managed at our institution, considered as an HV institute, were compared with that of cases operated at our institution following FNAC performed LV centres.The 159 PTC nodules included were classified as TIR3B (20.1%),TIR4 (32.7%),and TIR5 (47.2%).The distribution of FNAC report between HV and LV was different  (<jats:italic>p<\/jats:italic>\u2009=\u20090.01). The presence of lymph node metastasis  (<jats:italic>p<\/jats:italic>\u2009=\u20090.004), and peri-thyroid tissue invasion  (<jats:italic>p<\/jats:italic>\u2009=\u20090.02)increased according to the FNAC category. Significant difference among the three FNAC categories was also observed in PTC subtype  (<jats:italic>p<\/jats:italic>\u2009=\u20090.006)and Hashimoto\u2019s thyroiditis (<jats:italic>p<\/jats:italic>\u2009=\u20090.02).In addition, a significant different trend was found in ATA risk assessment, being the risk of recurrence more prevalent according to the FNAC category (<jats:italic>p<\/jats:italic>\u2009=\u20090.008). According to the second study aim, the higher prevalence of low-risk cases in TIR3B was confirmed in both HV (<jats:italic>p<\/jats:italic>\u2009=\u20090.04) and LV (<jats:italic>p<\/jats:italic>\u2009=\u20090.03)subgroups.PTCs with preoperative TIR3B have different histological features and ATA risk assessment with respect to cases with presurgical FNAC of TIR4\/5.Particularly, PTC from TIR3B should have a pattern of more indolent cancers. As non-negligible extension, this data is not influenced by the institutional setting with high or low thyroid-FNAC volume.<\/jats:p>","DOI":"10.1007\/s13304-025-02121-4","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T07:51:56Z","timestamp":1740556316000},"page":"907-913","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of histological features and recurrence risk assessment of papillary thyroid carcinoma according to presurgery FNAC category"],"prefix":"10.1007","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2413-2388","authenticated-orcid":false,"given":"Sium","family":"Wolde Sellasie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Amendola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leo","family":"Guidobaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Piticchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Nardone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Zaccaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Tacchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Pedicini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Uccioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierpaolo","family":"Trimboli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"issue":"8","key":"2121_CR1","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/j.1365-2362.2009.02162.x","volume":"39","author":"S Guth","year":"2009","unstructured":"Guth S, Theune U, Aberle J, Galach A, Bamberger CM (2009) Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination. Eur J Clin Invest 39(8):699\u2013706. https:\/\/doi.org\/10.1111\/j.1365-2362.2009.02162.x","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"2121_CR2","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1159\/000365289","volume":"3","author":"G Russ","year":"2014","unstructured":"Russ G, Leboulleux S, Leenhardt L, Heged\u00fcs L (2014) Thyroid incidentalomas: epidemiology, risk stratification with ultrasound and workup. Eur Thyroid J 3(3):154\u2013163. https:\/\/doi.org\/10.1159\/000365289","journal-title":"Eur Thyroid J"},{"key":"2121_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/EP161208.GL","volume":"22","author":"H Gharib","year":"2016","unstructured":"Gharib H et al (2016) American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules - 2016 Update Appendix. Endocr Pract 22:1\u201360. https:\/\/doi.org\/10.4158\/EP161208.GL","journal-title":"Endocr Pract"},{"issue":"9","key":"2121_CR4","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1001\/jama.2018.0898","volume":"319","author":"C Durante","year":"2018","unstructured":"Durante C, Grani G, Lamartina L, Filetti S, Mandel SJ, Cooper DS (2018) The diagnosis and management of thyroid nodules. JAMA 319(9):914. https:\/\/doi.org\/10.1001\/jama.2018.0898","journal-title":"JAMA"},{"key":"2121_CR5","volume-title":"SEER cancer statistics review, 1975\u20132016","author":"N Howlader","year":"2019","unstructured":"Howlader N et al (2019) SEER cancer statistics review, 1975\u20132016. National Cancer Institute, Bethesda"},{"issue":"4","key":"2121_CR6","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S2213-8587(22)00035-3","volume":"10","author":"M Pizzato","year":"2022","unstructured":"Pizzato M et al (2022) The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes Endocrinol 10(4):264\u2013272. https:\/\/doi.org\/10.1016\/S2213-8587(22)00035-3","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2121_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR et al (2016) 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1):1\u2013133. https:\/\/doi.org\/10.1089\/thy.2015.0020","journal-title":"Thyroid"},{"key":"2121_CR8","doi-asserted-by":"publisher","DOI":"10.1530\/ETJ-23-0067","author":"C Durante","year":"2023","unstructured":"Durante C et al (2023) 2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management. Eur Thyroid J. https:\/\/doi.org\/10.1530\/ETJ-23-0067","journal-title":"Eur Thyroid J"},{"issue":"6","key":"2121_CR9","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/cen.14882","volume":"98","author":"P Valderrabano","year":"2023","unstructured":"Valderrabano P, Eszlinger M, Stewardson P, Paschke R (2023) Clinical value of molecular markers as diagnostic and prognostic tools to guide treatment of thyroid cancer. Clin Endocrinol (Oxf) 98(6):753\u2013762. https:\/\/doi.org\/10.1111\/cen.14882","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2121_CR10","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2023.0141","author":"SZ Ali","year":"2023","unstructured":"Ali SZ, Baloch ZW, Cochand-Priollet B, Schmitt FC, Vielh P, VanderLaan PA (2023) The 2023 Bethesda System for reporting thyroid cytopathology. Thyroid\u00ae. https:\/\/doi.org\/10.1089\/thy.2023.0141","journal-title":"Thyroid\u00ae"},{"issue":"3","key":"2121_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s12022-020-09636-z","volume":"31","author":"A Crescenzi","year":"2020","unstructured":"Crescenzi A et al (2020) Exploring the Inter-observer Agreement Among the Members of the Italian Consensus for the Classification and Reporting of Thyroid Cytology. Endocr Pathol 31(3):301\u2013306. https:\/\/doi.org\/10.1007\/s12022-020-09636-z","journal-title":"Endocr Pathol"},{"key":"2121_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1001728","author":"L Scappaticcio","year":"2022","unstructured":"Scappaticcio L et al (2022) Repeat thyroid FNAC: Inter-observer agreement among high- and low-volume centers in Naples metropolitan area and correlation with the EU-TIRADS. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2022.1001728","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2121_CR13","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jacr.2017.01.046","volume":"14","author":"FN Tessler","year":"2017","unstructured":"Tessler FN et al (2017) ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee. J Am Coll Radiol 14(5):587\u2013595. https:\/\/doi.org\/10.1016\/j.jacr.2017.01.046","journal-title":"J Am Coll Radiol"},{"issue":"7","key":"2121_CR14","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s40618-018-0884-2","volume":"41","author":"F Pacini","year":"2018","unstructured":"Pacini F et al (2018) Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies. J Endocrinol Invest 41(7):849\u2013876. https:\/\/doi.org\/10.1007\/s40618-018-0884-2","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"2121_CR15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s12022-022-09729-x","volume":"33","author":"P Trimboli","year":"2022","unstructured":"Trimboli P, Ferrarazzo G, Cappelli C, Piccardo A, Castellana M, Barizzi J (2022) Thyroid nodules with indeterminate FNAC according to the Italian Classification System: Prevalence, Rate of Operation, and Impact on Risk of Malignancy. An Updated Systematic Review and Meta-analysis. Endocr Pathol 33(4):457\u2013471. https:\/\/doi.org\/10.1007\/s12022-022-09729-x","journal-title":"Endocr Pathol"},{"issue":"2","key":"2121_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/ejendo\/lvae012","volume":"190","author":"L Croce","year":"2024","unstructured":"Croce L et al (2024) The American Thyroid Association risk classification of papillary thyroid cancer according to presurgery cytology. Eur J Endocrinol 190(2):165\u2013172. https:\/\/doi.org\/10.1093\/ejendo\/lvae012","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"2121_CR17","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1210\/clinem\/dgae108","volume":"109","author":"M Endo","year":"2024","unstructured":"Endo M et al (2024) Indolent behavior of malignant Bethesda III nodules compared to Bethesda V\/VI nodules. J Clin Endocrinol Metab 109(9):2317\u20132324. https:\/\/doi.org\/10.1210\/clinem\/dgae108","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2121_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s12020-014-0453-1","volume":"49","author":"P Trimboli","year":"2015","unstructured":"Trimboli P et al (2015) Differentiated thyroid cancer patients with a previous indeterminate (Thy 3) cytology have a better prognosis than those with suspicious or malignant FNAC reports. Endocrine 49(1):191\u2013195. https:\/\/doi.org\/10.1007\/s12020-014-0453-1","journal-title":"Endocrine"},{"issue":"1","key":"2121_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11154-023-09846-w","volume":"25","author":"VA dos Santos Valsecchi","year":"2024","unstructured":"dos Santos Valsecchi VA, Betoni FR, Ward LS, Cunha LL (2024) Clinical and molecular impact of concurrent thyroid autoimmune disease and thyroid cancer: from the bench to bedside. Rev Endocr Metab Disord 25(1):5\u201317. https:\/\/doi.org\/10.1007\/s11154-023-09846-w","journal-title":"Rev Endocr Metab Disord"},{"key":"2121_CR20","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvac157","author":"C Sparano","year":"2022","unstructured":"Sparano C et al (2022) Classic and follicular variant of papillary thyroid microcarcinoma: 2 different phenotypes beyond tumor size. J Endocr Soc. https:\/\/doi.org\/10.1210\/jendso\/bvac157","journal-title":"J Endocr Soc"},{"key":"2121_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12020398","author":"S Amendola","year":"2023","unstructured":"Amendola S et al (2023) Evaluation of the performance of ACR TI-RADS also considering those nodules with no indication of FNAC: A single-center experience. J Clin Med. https:\/\/doi.org\/10.3390\/jcm12020398","journal-title":"J Clin Med"}],"container-title":["Updates in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-025-02121-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13304-025-02121-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-025-02121-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T14:48:57Z","timestamp":1751554137000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13304-025-02121-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["2121"],"URL":"https:\/\/doi.org\/10.1007\/s13304-025-02121-4","relation":{},"ISSN":["2038-131X","2038-3312"],"issn-type":[{"value":"2038-131X","type":"print"},{"value":"2038-3312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"assertion":[{"value":"14 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in this study were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"All subjects gave written informed consent for their participation in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}